Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
Fierce Pharma7d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
Everyday Health on MSN4d
FDA Approves the First New UTI Antibiotic in Nearly 30 Years
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
KTBS 36d
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
MPR1d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
Managed Healthcare Executive6d
FDA Approves UTI Antibiotic, Blujepa
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
Contract Pharma6d
GSK’s Blujepa Approved by FDA for Treatment of uUTIs
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
GSK's Blujepa Approved For Treatment of UTIs in Women, Children
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
Fast Company6d
Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
The Food and Drug Administration (FDA) has approved a new drug, Blujepa, the first of a new class of oral antibiotics for treating UTIs, to head to market. Drugmaker GSK plans to release the ...